Uro Vaxom is an oral treatment designed to prevent recurrent urinary tract infections (UTIs). Recurrent UTIs often require repeated courses of antibiotics, which can lead to bacterial resistance. This medication offers a non-antibiotic strategy by working with the body’s natural defense systems.
How Uro Vaxom Stimulates Immune Protection
Uro Vaxom is classified as an oral immunostimulant, activating the body’s immune defenses against future infections. The capsule contains 6 milligrams of lyophilized bacterial lysate, a non-living mixture of components from 18 strains of Escherichia coli. Since E. coli causes over 85% of UTIs, this lysate targets the primary pathogen.
Once ingested, the bacterial lysate travels to the gut-associated lymphoid tissue (GALT), where immune cells recognize it. This oral exposure primes the immune system by activating specialized cells like T-lymphocytes and macrophages. These stimulated immune cells then migrate to the urinary tract lining, bolstering local defense mechanisms.
The key protective action involves stimulating the production of specific antibodies, particularly Immunoglobulin A (IgA) and Immunoglobulin G (IgG). IgA is secreted onto the mucosal surfaces of the urinary tract, acting as a defensive barrier that prevents E. coli from adhering to the bladder wall. By enhancing this localized, long-term mucosal immunity, Uro Vaxom reduces the frequency and severity of recurrent UTIs.
Guidelines for Taking Uro Vaxom
The standard regimen for Uro Vaxom is designed for prevention, not for the treatment of an acute infection.
Prevention Regimen
For preventing recurrent UTIs, the typical protocol is one capsule taken daily in the morning, preferably on an empty stomach for optimal absorption. The prevention phase is recommended to last for three consecutive months (90 days). Completing the full course is important to allow the immune system time to establish a lasting protective response, even if the patient remains symptom-free.
Use During Acute Infection
Uro Vaxom may be used alongside traditional antimicrobial therapy during an acute UTI episode. In this scenario, one capsule is taken daily for a minimum of ten consecutive days, or until symptoms disappear. If a dose is missed, take it as soon as it is remembered, unless it is close to the next scheduled dose, in which case the patient should continue with the regular schedule.
Understanding the Safety Profile
Uro Vaxom is generally well-tolerated and has a favorable safety profile compared to the risks associated with long-term antibiotic prophylaxis. The majority of reported side effects are mild and transient. The most common adverse reactions involve the digestive system, such as mild nausea, diarrhea, or stomach discomfort. Other infrequent side effects include headaches or mild skin reactions like a rash.
If severe symptoms occur, such as a high fever, widespread skin reactions, or signs of a serious allergic reaction, discontinue the medication and seek medical attention immediately.
Contraindications include known hypersensitivity to any component of the capsule. Individuals taking immunosuppressant drugs should consult their healthcare provider, as these medications may reduce Uro Vaxom’s effectiveness. Use during pregnancy and breastfeeding is generally not recommended due to limited data.